Device and surgical treatment of patients with heart failure based on the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure

Management of all patients with heart failure and reduced left ventricular ejection fraction is based on optimal drug treatment - „the great four” that reduce mortality (1-angiotensin converting enzyme inhibitors or angiotensin receptor neprilyzine inhibitor; 2-beta-adrenoblockers; 3-mineralocortico...

Full description

Saved in:
Bibliographic Details
Published inBuletinul Academiei de Ştiinţe a Moldovei. Ştiinţe medicale Vol. 72; no. 1; pp. 82 - 90
Main Authors Moscalu, Vitalie, Racila, Valentin, Rizov, Mihail, Gutan, Inesa
Format Journal Article
LanguageEnglish
Published 01.04.2022
Online AccessGet full text

Cover

More Information
Summary:Management of all patients with heart failure and reduced left ventricular ejection fraction is based on optimal drug treatment - „the great four” that reduce mortality (1-angiotensin converting enzyme inhibitors or angiotensin receptor neprilyzine inhibitor; 2-beta-adrenoblockers; 3-mineralocorticoid receptor antagonists; 4-sodium-glucose cotransporter inhibitors-2). For certain categories of patients, treatments with implantable cardiac devices (CRT-P/D or ICD) and cardiac surgery (coronary artery bypass grafting, aortic or mitral valve repair operations) that improve the life prognosis are required, and for advanced heart failure may be considered methods of mechanical circulatory support and heart transplantation.
ISSN:1857-0011
DOI:10.52692/1857-0011.2022.1-72.13